Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection

Figure 1 Patients were distributed to three groups according to the results of hepatitis B surface antigen and hepatitis B core antibodies. anti-HBc: Hepatitis B core antibodies; anti-HCV: Antibodies against hepatitis C virus; HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus.

Figure 2 Metabolic associated steatotic liver disease patients were distributed to two groups based on the status of hepatitis B surface antigen. HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus; MASLD: Metabolic dysfunction-associated steatotic liver disease.

Figure 3 Patients with positive hepatitis B surface antigen were distributed to two groups based on the status of metabolic dysfunction-associated steatotic liver disease. anti-HBc: Hepatitis B core antibodies; HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus; MASLD: Metabolic dysfunction-associated steatotic liver disease.